Financhill
Back

MoonLake Immunotherapeutics Stock Price Chart

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
69

MLTX
MoonLake Immunotherapeutics

Last Price:
51.89
Seasonality Move:
15.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MoonLake Immunotherapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 49.36 Buy
20-day SMA: 48.49 Buy
50-day SMA: 49.47 Buy
200-day SMA: 47.19 Buy
8-day EMA: 50.37 Buy
20-day EMA: 49.3 Buy
50-day EMA: 48.81 Buy
200-day EMA: 46.99 Buy

MoonLake Immunotherapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 65.2 Buy
Chaikin Money Flow: 197472 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.64 - 50.58) Buy
Bollinger Bands (100): (43.3 - 50.84) Buy

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for MoonLake Immunotherapeutics Stock

Is MoonLake Immunotherapeutics Stock a Buy?

MLTX Technical Analysis vs Fundamental Analysis

Buy
69
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics a Buy or a Sell?

MoonLake Immunotherapeutics Stock Info

Market Cap:
3.39B
Price in USD:
53.89
Share Volume:
267.06K

MoonLake Immunotherapeutics 52-Week Range

52-Week High:
64.98
52-Week Low:
35.53
Buy
69
MoonLake Immunotherapeutics (MLTX) is a Buy

MoonLake Immunotherapeutics Share Price Forecast

Is MoonLake Immunotherapeutics Stock a Buy?

Fundamental Analysis of MoonLake Immunotherapeutics

Is MoonLake Immunotherapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.69 per share.

Technical Analysis of MoonLake Immunotherapeutics

Should I short MoonLake Immunotherapeutics stock?

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.